A Chinese factory that has not been inspected by the Food and Drug Administration is the source for the active ingredient of a critical blood-thinning drug whose production was suspended this week after 350 patients reported ill effects from it.
At least four people died after being given the drug, heparin.
An FDA spokeswoman, Heidi Robello, said on Wednesday that the agency was making plans to inspect the Chinese factory as well as a finishing plant in New Jersey "as soon as possible."
She said that "it was yet to be determined" if the Chinese plant was the source of the problem that led to the spike in reports of problems with the drug's use.
Heparin is made from pig intestines. Robello said that she did not know whether the pigs used to produce the suspended product, made by Baxter International, came from China.
Heparin is used widely in dialysis, heart surgery and chronic care hospitals. Baxter manufactures half of the nation's supply of the drug, and the company's suspension of production of multiuse heparin vials is expected to lead to shortages.
Baxter spokeswoman Erin Gardiner said her company bought the active ingredient for the drug from another concern, which she would not identify. She said that company had plants in the US and China.
The Government Accountability Office recently reported that at its current inspection pace, the FDA would need at least 13 years to inspect every foreign drug plant that exports products to the US. The office, an independent arm of Congress, also found that the FDA's computer systems were deficient and it had little idea how many plants had been approved for exports to the US.
SAFETY RISK: The government is working to categorize countries based on their COVID-19 cases and prevention efforts, which would determine quarantine periods The government plans to rank countries based on their COVID-19 risks to determine how to treat tourists and other travelers from those nations once Taiwan reopens its borders, but it is still working out the categories, a top health official told lawmakers yesterday. “We would divide countries around the world into several categories. One category would comprise those countries with very few confirmed COVID-19 cases, such as New Zealand and Palau. Travelers from the countries in this category would only need to practice self-health management,” Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥) told a Legislative Yuan seminar hosted by
China would attack Taiwan if there is no other way of stopping it from becoming independent, Chinese General Li Zuocheng (李作成) said yesterday. Speaking at Beijing’s Great Hall of the People on the 15th anniversary of China’s “Anti-Secession” Law, Li, who is chief of the Joint Staff Department of the Chinese People’s Liberation Army Central Military Commission, left the door open to using force. The 2005 law is China’s legislative basis for military action against Taiwan. “If the possibility for peaceful reunification is lost, the people’s armed forces will, with the whole nation, including the people of Taiwan, take all necessary steps to
SECURITY CONCERNS: The Telecom Technology Center ran black-box tests for the Executive Yuan on devices and software from Chinese, US and South Korean firms Network devices from several Chinese manufacturers are insecure and allow personal information to be leaked, testing commissioned by the Executive Yuan has shown. A variety of devices and software, including apps, from Chinese, US and South Korean manufacturers that are used by government agencies at the central and local level were subjected to black-box testing — in which the functionality of an application is examined without knowing about its internal structure, an information-security official said yesterday on condition of anonymity. The Telecom Technology Center conducted the tests, which simulated cyberattacks, to determine their resilience to the attacks, the official said. The center
RELATIONSHIP ‘TERMINATED’: US Speaker Nancy Pelosi said that the president’s action was ‘an act of extraordinary senselessness,’ a tone Chinese media echoed US President Donald Trump on Friday announced that Washington would withdraw funding from the WHO, end Hong Kong’s special trade status and suspend visas of Chinese graduate students suspected of conducting research on behalf of their government. Trump said in a White House announcement that Chinese officials “ignored” their reporting obligations to the WHO and pressured the organization to mislead the public about the outbreak. “We have detailed the reforms that it must make and engaged with them directly, but they have refused to act,” he said. “Because they have failed to make the requested and greatly needed reforms, we will be